CR1L
Basic information
Region (hg38): 1:207645113-207738416
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CR1L gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 35 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 35 | 7 | 0 |
Variants in CR1L
This is a list of pathogenic ClinVar variants found in the CR1L region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-207645238-C-T | not specified | Uncertain significance (Mar 05, 2024) | ||
1-207645264-T-C | not specified | Uncertain significance (Apr 07, 2023) | ||
1-207645284-T-A | Likely benign (Jul 01, 2022) | |||
1-207645298-C-A | not specified | Uncertain significance (Jun 01, 2023) | ||
1-207677404-C-T | not specified | Uncertain significance (Feb 03, 2022) | ||
1-207677487-C-T | not specified | Uncertain significance (Feb 05, 2024) | ||
1-207677509-C-G | not specified | Uncertain significance (Nov 08, 2022) | ||
1-207677533-A-G | not specified | Uncertain significance (Jun 22, 2023) | ||
1-207678221-G-C | not specified | Uncertain significance (Mar 26, 2024) | ||
1-207678237-T-C | not specified | Uncertain significance (Apr 24, 2023) | ||
1-207678249-T-A | not specified | Uncertain significance (Sep 14, 2022) | ||
1-207678255-A-G | not specified | Uncertain significance (Apr 27, 2024) | ||
1-207683889-C-A | not specified | Uncertain significance (Oct 12, 2021) | ||
1-207683892-C-T | not specified | Uncertain significance (Mar 15, 2024) | ||
1-207694361-T-C | not specified | Uncertain significance (Nov 17, 2022) | ||
1-207694382-G-A | not specified | Uncertain significance (Mar 21, 2023) | ||
1-207694446-A-G | not specified | Likely benign (Mar 31, 2023) | ||
1-207694474-G-T | not specified | Uncertain significance (Jan 04, 2024) | ||
1-207694540-G-C | not specified | Uncertain significance (Feb 17, 2022) | ||
1-207694664-C-G | not specified | Uncertain significance (Sep 01, 2021) | ||
1-207694667-C-T | not specified | Uncertain significance (Dec 28, 2023) | ||
1-207694693-C-T | Likely benign (Jul 01, 2022) | |||
1-207694716-A-G | not specified | Uncertain significance (Jul 05, 2023) | ||
1-207697539-G-A | not specified | Likely benign (Jul 09, 2021) | ||
1-207697552-C-G | not specified | Uncertain significance (Nov 06, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CR1L | protein_coding | protein_coding | ENST00000508064 | 12 | 93304 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.64e-27 | 0.0000143 | 124475 | 1 | 165 | 124641 | 0.000666 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.670 | 342 | 309 | 1.11 | 0.0000161 | 3706 |
Missense in Polyphen | 102 | 97.67 | 1.0443 | 1218 | ||
Synonymous | -1.96 | 140 | 114 | 1.23 | 0.00000599 | 1099 |
Loss of Function | -1.14 | 36 | 29.3 | 1.23 | 0.00000177 | 329 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000738 | 0.000738 |
Ashkenazi Jewish | 0.0000994 | 0.0000994 |
East Asian | 0.00101 | 0.00100 |
Finnish | 0.0000494 | 0.0000464 |
European (Non-Finnish) | 0.000569 | 0.000566 |
Middle Eastern | 0.00101 | 0.00100 |
South Asian | 0.00190 | 0.00186 |
Other | 0.000828 | 0.000826 |
dbNSFP
Source:
Intolerance Scores
- loftool
- 0.821
- rvis_EVS
- 3.87
- rvis_percentile_EVS
- 99.65
Haploinsufficiency Scores
- pHI
- 0.0696
- hipred
- N
- hipred_score
- 0.139
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.544
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cr1l
- Phenotype
- renal/urinary system phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- Cellular component
- extracellular region;cytoplasm;membrane;receptor complex
- Molecular function